checkAd
    Startseite > Aktien > Pacira BioSciences > Nachrichten
    Pacira BioSciences Aktie
    30,38
     
    USD
    +3,26 %
    +0,96 USD
    Letzter Kurs 02:00:00 Nasdaq
    30,34
     
    USD
    700 STK
    Geldkurs 13.05.24
    30,38
     
    USD
    1.100 STK
    Briefkurs 13.05.24
    ISIN: US6951271005 · WKN: A1H68T · SYM: PCRX · USA

    Neueste Nachrichten

    Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029
    10.05.24 · globenewswire · Pacira BioSciences
    Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
    08.05.24 · globenewswire · Pacira BioSciences
    Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program
    07.05.24 · globenewswire · Pacira BioSciences
    Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
    07.05.24 · globenewswire · Pacira BioSciences
    Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
    30.04.24 · globenewswire · Pacira BioSciences
    Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
    02.04.24 · globenewswire · Pacira BioSciences
    Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee
    13.03.24 · globenewswire · Pacira BioSciences
    Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference
    06.03.24 · globenewswire · Pacira BioSciences
    Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
    29.02.24 · globenewswire · Pacira BioSciences
    Pacira to Report 2023 Financial Results on Thursday February 29, 2024
    22.02.24 · globenewswire · Pacira BioSciences
    Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
    15.02.24 · globenewswire · Pacira BioSciences
    Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
    07.02.24 · globenewswire · Pacira BioSciences